-
Cooking Together: promotions and resource development
https://braincanada.ca/funded-grants/cooking-together-promotions-and-resource-developmentCooking Together is an innovative project that provides the opportunity for developing new relationships between generations while cooking and eating together. Project Overview Cooking Together is an innovative project that provides the opportunity for developing new relationships between...
-
Coordinating Global Brain Projects
https://braincanada.ca/about/news-updates/coordinating-global-brain-projectsInez Jabalpurwala, Brain Canada’s President and CEO, speak at the at Rockefeller University on September 19, 2016.
-
Correction of Neuronal Function in Autism
https://braincanada.ca/funded-grants/correction-of-neuronal-function-in-autismThe prevalence of autism spectrum disorders (ASDs) is rising dramatically on a yearly basis and new interventional strategies are required to treat ASDs and related disorders like Fragile X syndrome. Project Overview The prevalence of autism spectrum disorders (ASDs) is rising dramatically on a...
-
Correlating quaternary structure of pathological protein aggregates with phenotypic presentation of ALS
https://braincanada.ca/funded-grants/correlating-quaternary-structure-of-pathological-protein-aggregates-with-phenotypic-presentation-of-alsAmyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset. Project Overview Amyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset. The disease can start in one arm, leg,...
-
Cortical GABAergic interneurons migration impairment in genetic epileptic encephalopathies
https://braincanada.ca/funded-grants/cortical-gabaergic-interneurons-migration-impairment-in-genetic-epileptic-encephalopathiesDr. Eid will test the hypothesis that the Trio gene is a central regulator of the development and maturation of cortical interneurons (INs) and that its loss underlies some genetic forms of epileptic encephalopathies (EE) by disrupting cortical network development and function. Project Overview Dr....
-
Could a ketogenic diet slow the progression of ALS?
https://braincanada.ca/about/news-updates/could-a-ketogenic-diet-slow-the-progression-of-als“Increase your caloric intake.” This is the number one recommendation that a clinician will make to a person recently diagnosed with Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease affecting nerve cells in the brain and spinal cord, causing loss of muscle control. A high calorie...
-
Could inflammation in this pathway provide a new target for ALS therapies?
https://braincanada.ca/about/news-updates/could-inflammation-in-this-pathway-provide-a-new-target-for-als-therapiesDr. Honglin Luo (left) and Dr. Neil Cashman. Discovery Grant empowers Canadian team to examine the cGAS-STING pathway across a range of ALS models “The Discovery Grant is very crucial for us,” says Dr. Luo, “since it allows us to quickly look at the outcome.” Dr. Cashman also emphasizes speed as a...
-
Could mindfulness improve quality of life for people living with ALS?
https://braincanada.ca/about/news-updates/could-mindfulness-improve-quality-of-life-for-people-living-with-alsDiscovery Grant will fuel an interdisciplinary mindfulness study for people living with ALS and their caregivers “Research suggests that being more mindful may allow people a greater sense of perceived control. This is doubly relevant because an ALS diagnosis can bring about elements of fear and...
-
CQDM and Brain Canada Inject $1 M in Top BC Biotech Firm AbCellera to Advance Discovery Platform for Next-Generation Antibody Therapeutics
https://braincanada.ca/about/news-updates/cqdm-and-brain-canada-inject-1-m-in-top-bc-biotech-firm-abcellera-to-advance-discovery-platform-for-next-generation-antibody-therapeuticsThe program will leverage AbCellera’s high-throughput, single-cell screening platform to allow rapid identification of functional antibodies against complex membrane proteins. MONTREAL, January 12th, 2018– CQDM and Brain Canada are proud to announce the non-dilutive funding of $1 M to AbCellera and...
-
CQDM, Brain Canada and industry partners join forces to address unmet medical needs
https://braincanada.ca/about/news-updates/cqdm-brain-canada-and-industry-partners-join-forces-to-address-unmet-medical-needsCQDM and Brain Canada are proud to announce the funding of three collaborative research projects, for a total of $7.4 million which includes financial support from various industry partners, aimed at addressing unmet needs in the treatment of brain disorders. These projects are made possible by a...